Search - tctmd.com

Displaying 181 - 200 of 219

Sort: Relevancy | Date

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Jason Kahn

July 05, 2013

News Daily News

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

L.A. McKeown

April 26, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

Presentation

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Presenter: Siddharth A. Wayangankar

April 19, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

L.A. McKeown

January 06, 2013

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

August 14, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

Advertisement

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content